ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,736Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 910

$925K Total Retail Price of All Prescriptions

Rank: 28 out of 910

947 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 947 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

8% of this provider’s 947 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 9,950 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 562 435 1 1
LISINOPRIL 518 422 2 2
SIMVASTATIN 475 375 3 3
AMLODIPINE BESYLATE 473 414 4 4
METFORMIN HCL 403 291 5 6
OMEPRAZOLE 335 286 6 5
HYDROCODONE-ACETAMINOPHEN 311 226 S3 7 8
HYDROCHLOROTHIAZIDE 269 245 8 12
FUROSEMIDE 260 200 9 9
ATENOLOL 222 174 10 10
ZOLPIDEM TARTRATE 210 144 11 17
CITALOPRAM HBR 189 136 12 19
WARFARIN SODIUM 177 153 13 11
METOPROLOL TARTRATE 171 131 14 7
LOVASTATIN 163 124 15 20
RANITIDINE HCL 160 137 16 28
ATORVASTATIN CALCIUM 160 154 16 14
GABAPENTIN 134 82 18 13
POTASSIUM CHLORIDE 134 98 18 18
GLYBURIDE 132 121 R 20 46
LANTUS 123 56 21 30
PRAVASTATIN SODIUM 121 105 22 16
METOPROLOL SUCCINATE 118 103 23 21
LOSARTAN POTASSIUM 111 94 24 15
PROAIR HFA 103 59 25 40
TERAZOSIN HCL 94 94 26 61
CARVEDILOL 94 77 26 36
CARISOPRODOL 89 76 R 28 71
GLIPIZIDE 84 58 29 38
BENAZEPRIL HCL 83 76 30 89
FLUTICASONE PROPIONATE 83 60 30 23
ALENDRONATE SODIUM 82 73 32 22
PAROXETINE HCL 82 68 32 50
EXFORGE 81 76 34 198
TRIAMTERENE-HCTZ 78 69 35 39
ALLOPURINOL 77 71 36 33
HUMALOG 77 46 36 128
TRAMADOL HCL 75 61 38 25
TRAZODONE HCL 72 36 39 37
CLOPIDOGREL 72 60 39 35
CRESTOR 70 55 41 26
OXYCODONE HCL-ACETAMINOPHEN 69 42 S2 42 114
VYTORIN 68 56 43 82
DIOVAN 67 61 44 34
ADVAIR DISKUS 65 41 45 45
SERTRALINE HCL 64 58 46 24
AZITHROMYCIN 63 45 47 41
NAPROXEN 63 58 47 96
FLUOXETINE HCL 61 60 49 49
CYCLOBENZAPRINE HCL 61 26 R 49 80
JANUVIA 60 52 51 69
TRICOR 60 46 51 153
MORPHINE SULFATE ER 60 32 S2 51 52
DOXAZOSIN MESYLATE 59 52 54 62
PANTOPRAZOLE SODIUM 58 39 55 27
CELEBREX 58 53 55 85
INSULIN SYRINGE 57 41 57 47
SYNTHROID 55 51 58 54
MELOXICAM 54 54 59 76
CLONIDINE HCL 54 31 59 51
ACTOS 54 45 59 86
LEVOXYL 54 52 59 106
FENOFIBRATE 54 46 59 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 32 64 44
QUINAPRIL HCL 52 48 64 148
OXYCODONE-ACETAMINOPHEN 51 39 S2 66 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.